StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.85−0.11 (-5.61%)

Close on Nov 16, 2026Market cap $56.40MP/E –Yield –

XBiotech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

XBiotech's pe ratio was 1.3× on Jan 29, 2021.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Jan 29, 20211.3×+0.2
2020Dec 31, 20201.1×–

More XBiotech figures

See a number that looks wrong?